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Abstract 
Macrophages play an important role in regulating inflammatory responses and tissue regeneration. In 
the present study, their effect on bone remodeling is investigated by the simultaneous application of 
a macrophage recruiting agent, SEW2871 of a sphingosine-1 phosphate agonist, and platelet-rich 
plasma (PRP). The non-water soluble SEW2871 was solubilized in water through micelles formation 
with L-lactic acid grafted gelatin, and the resulting micelles with PRP were incorporated into gelatin 
hydrogels. Mixed SEW2871-micelles and PRP were released from gelatin hydrogels in a controlled 
fashion both in vitro and in vivo. In vitro migration assay revealed that the presence of PRP 
synergistically promoted SEW2871-induced macrophages migration. When applied to a bone defect 
of rats, the hydrogels incorporating mixed SEW2871-micelles and PRP recruited a higher number of 
macrophages than those hydrogels incorporating either SEW2871-micelles or PRP. The hydrogels 
incorporating mixed SEW2871-micelles and PRP enhanced the level of tumor necrosis factor 
(TNF)-α of pro-inflammatory cytokine, 3 days after application, while pro-inflammatory responses 
coupled with a significant increase in the expression level of osteoprotegerin (OPG) and interleukin 
(IL)-10 and transforming growth factor (TGF)-β1 of anti-inflammatory cytokine were observed 10 
days postoperatively. The hydrogels incorporating mixed SEW2871-micelles and PRP promoted 
bone regeneration to a significant great extent compared with those incorporating PBS and either 
SEW2871-micelles or PRP. It is concluded that macrophages recruitment contributed to PRP-
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1. Introduction  
Bone tissue engineering has been noted as an interdisciplinary method to enhance therapeutic 
efficacy by making use of biomaterials. Cells and bioactive molecules are incorporated into 
biomaterial scaffolds which can provide a suitable environment for cell-based bone regeneration. 
The process of bone healing involves complicated molecular signaling and significant changes in the 
expression of several genes from various types of cells, which can mediate bone formation and 
regeneration [1, 2]. Among the cells, resident and infiltrated inflammatory cells, such as 
macrophages, play an immediate and pivotal role in the initiation, maintenance, and resolution of 
inflammation after bone fracture or injury [3-5]. Macrophages are generally recruited from the blood 
circulation, function for phagocytosis of apoptotic cells, and play a critical role in the production of 
growth factors, cytokines, and inflammatory mediators which participate in both modulation of 
inflammation and regeneration of tissues [6-8]. However, this inflammatory process may fail to 
resolve the foreign body reactions to implanted materials, resulting in tissue regeneration delay or 
suppression. Indeed, it has been demonstrated that the inflammation response is closely related to the 
timing to naturally induce tissue regeneration [9, 10]   
The modulation of inflammation by macrophages has been increasingly investigated [8, 11-
13].  It has been demonstrated that the decreased number of macrophages generally implicates  
their dysfunction of dead cell clearance, the phagocytosis of apoptotic cells, and the up-regulation of 
pro-inflammatory cytokines, including interleukin (IL)-6, and tumor necrosis factor (TNF)-α. This 
may induce inflammation and delayed tissue repair. For bone regeneration, macrophages are able to 
differentiate into multinucleate osteoclasts that induce bone resorption, while osteoblasts 
differentiated from mesenchymal stem cells stimulate bone formation. The ratio of osteoclasts to 
osteoblasts affects bone homeostasis. Therefore, the proper number of macrophages may be required 
not only to modulate inflammation, but also to enhance bone regeneration.   
SEW2871 (5-[4-Phenyl-5-(trifluoromethyl) thiophen-2-yl]-3-[3-(trifluoromethyl) phenyl] 
1,2,4-oxadiazole), a sphingosine-1-phosphate (S1P)1-selective agonist, can induce the recruitment of 
macrophages [14, 15]. The S1P binds to a family of G protein-coupled receptors, called S1P 
receptors 1 to 5. They affect multiple biological functions including cells proliferation, cytoskeletal 
organization, differentiation, and migration [16]. Among the S1P receptor agonists, SEW2871 is not 
active for the S1P2-5 receptors unlike FTY720 of a nonselective S1P receptor agonist. It has been 
shown that SEW2871 does not cause coronary artery muscle contraction nor does cause bradycardia 
which is mediated via S1P2 and S1P3. Furthermore, it has been found that the receptor binding and 
signaling of SEW2871 and natural ligand S1P induce S1P1 internalization and recycling. This is in 
contrast to FTY 720, which induces receptor degradation [17]. Consequently, SEW2871 may have 
advantages over non-selective S1P receptor agonists. However, the water insolubility of SEW 2871 
may limit the therapeutic application.  
Platelet-rich plasma (PRP) has been proposed to enhance tissue regeneration, such as the 
wound healing of soft and bone tissues [18, 19]. It contains several autologous growth factors, such 
as transforming growth factor (TGF)-β1, platelet derived growth factor (PDGF), vascular endothelial 
growth factor (VEGF), epithelial growth factor (EGF), and stromal cell derived factor-1 (SDF-1). 
Recent studies have demonstrated that bioactive PRP released from gelatin hydrogels enhances 
angiogenesis and osteogenesis [20, 21]. 
This study is undertaken to investigate the effect of macrophages recruitment on growth 
factor-induced bone regeneration. It has been experimentally confirmed that PRP release from the 
gelatin hydrogels promoted bone regeneration [22, 23]. No researches on the PRP-induced bone 
regeneration in terms of macrophages recruitment have been reported.  
SEW2871 of a macrophage recruitment agent was water-solubilized through the micelle 
formation with L-lactic acid oligomer-grafted gelatin micelles. The micelles of SEW2871 water-
solubilized and PRP were incorporated into the gelatin hydrogels. Their in vitro and in vivo release 
profiles from the gelatin hydrogels were evaluated. The in vitro macrophages migration and in vivo 
macrophages recruitment by the hydrogels incorporating SEW2871-micelles and/or PRP were 
investigated to compare with those of hydrogels incorporating either one. The bone gormation was 
evaluated by histoloical, radiological, and macro-computed tomographic examinations. We 
examined the expression levels of inflammatory cytokines and osteoprotegerin (OPG) of 
osteoclastogenesis inhibitory factor, genes after implantation of the gelatin hydrogels.  
  
2. Materials and methods  
2.1 Materials 
A gelatin sample prepared by an acidic treatment of porcine skin collagen (isoelectric point 
(IEP) =5.0) was kindly supplied by Nitta Gelatin Inc., Osaka, Japan. 5-[4-Phenyl-5-
(trifluoromethyl)thiophen-2-yl]-3-[3-(trifluoromethyl)phenyl]1,2,4-oxadiazole (SEW2871) was 
purchased from Cayman Chemical, Ann Arbor, MI, USA. Na
125
I (NEZ-033H, >12.95 GBq/ml) and 
N’-succinimidyl-3-(4-hydroxy-3,5-di[125I]iodophenyl) propionate or [125I] Bolton-Hunter reagent 
(NEX-120H, 147 MBq/ml) were purchased from Perkine Elmer Life Sciences Inc., Boston, MA. 
 
2.2. Synthesis of L-lactic acid oligomer-grafted gelatin 
L-lactic acid oligomer with a number-average molecular weight of 1,000 was synthesized 
from L-lactide monomer by ring-opening polymerization, as reported previously [24]. Briefly, L-
lactic acid oligomer (3 ×  10-5 mole) was dissolved in 15 ml of Dimethyl sulfoxide (DMSO), while 
disuccinimidyl carbonate (DSC, 9 ×  10-5 mole) and dimethyl amino pyridine (DMAP, 9 ×  10-5 
mole) were dissolved in 2.5 ml of the DMSO solution. The solution was mixed to activate the 
hydroxyl groups of L-lactic acid oligomer for 3 hr at room temperature. The solution of activated L-
lactic acid oligomer was slowly added to the gelatin (IEP = 5) solution in DMSO (33 mg/ml), and 
the mixture was stirred overnight at room temperature to chemically graft the L-lactic acid oligomer 
to gelatin. To obtain the L-lactic acid oligomer-grafted gelatin, the resulting solution was dialyzed 
against double-distilled water (DDW) using a dialysis tube (molecular weight cut off = 
12,000~14,000) at room temperature for 72 hr, followed by freeze drying The ratio of L-lactic acid 
oligomer grafted to the amino groups of gelatin determined by the fluorescamine assay was 3.1 ± 0.8 
mole/mole gelatin, as reported previously [25].  
 
2.3. Preparation of L-lactic acid oligomer-grafted gelatin and SEW2871 micelles 
L-lactic acid oligomer-grafted gelatin solution (1 mg/ml) in DMSO and SEW2871 solution 
(1 mg/ml) in DMSO were prepared. The SEW2871 solution (15 ml) was added to the L-lactic acid 
oligomer-grafted gelatin solution (30 ml), followed by stirring at room temperature for 3 hr. The 
reaction mixture was dialyzed using a dialysis tube (molecular weight cut off = 1000) for 72 hr. The 
dialysate obtained was centrifuged at 8,000 rpm, 4 °C for 10 min to separate water-insoluble 
SEW2871, and freeze-dried to obtain the SEW2871 water-solubilized by L-lactic acid oligomer-
grafted to measure the amount of SEW2871 incorporated into the micelles. The SEW2871-micelles 
freeze-dried were dissolved in 100 vol% acetonitrile and subjected to high-performance liquid 
chromatography (HPLC) (LC-8020 model-II, Tosoh, Tokyo, Japan). The concentration of SEW2871 
was determined from the calibration curve prepared with the 100 vol% acetonitrile containing various 
amounts of SEW2871.  
 
2.4. Preparation of PRP  
F344 rats (12 weeks old; Shimizu Laboratory Animal Supply Co.,Ltd, Kyoto, Japan) were 
used. All the animal experiments were performed according to the Institutional Guidance of Kyoto 
University on Animal Experimentation and under permission by animal experiment committee of 
Institute for frontier Medical Science, Kyoto University. Briefly, rats were anesthetized by the 
intraperitoneal injection of pentobarbital (Somnopentyl, Kyoritsu Seiyaku Co., Tokyo, Japan) at a 
dose of 0.65 mg kg
-1
 body weight. PRP was prepared and activated with CaCl2 according to the 
method reported previously [26]. Briefly, blood (10 ml) was collected from the heart of rats and 
transferred into tubes containing acid-citrate-dextrose solution formula A (1:4 v/v) anticoagulant. 
After centrifugation for 7 min at 1,000g and 4 °C, the yellow plasma with the buffy coat was carefully 
transferred into a BD Vacutainer tube (Becton Dickinson Co., NJ, USA), and then centrifuged for 5 
min at 2,100 g and 4 °C. The platelet pellet was collected and the thrombolytic pellet in 1.0 ml of 
plasma was used as PRP, while the supernatant provided platelet-poor plasma (PPP). To allow growth 
factors to release from PRP, the PRP prepared was mixed with 2 wt.% CaCl2 solution at a ratio of 7:1 
by volume, and then left for 1 hr at 37 °C according to the method reported previously [20].  
 2.5. Preparation of gelatin hydrogels incorporating mixed SEW2871-micelles and PRP 
A gelatin solution (5 wt%, IEP = 5.0) solution was mixed with 0, 7.5 or 15 μg of SEW2871-
micelles and cast into a Tissue-Tek
®
 mold (Sakura Finetek Japan Co., Ltd., Tokyo, Japan), followed 
by freeze-drying. The hydrogels (2 x 2 x 6 mm
3
) were crosslinked dehydrothermal (DHT) treatment at 
140 °C for 48 hr in a vacuum oven [27] and sterilized by ethylene oxide. Prior to the following 
experiments, PRP prepared (20 μl) was impregnated into a gelatin hydrogel incorporating SEW2871-
micelles, followed by leaving at 4 °C overnight to prepared the hydrogels incorporating mixed 
SEW2871-micelles and PRP.  
 
2.6. In vitro and in vivo release tests of SEW2871 from gelatin hydrogels incorporating mixed 
SEW2871-micelles and PRP 
To evaluate in vitro release of SEW2871 micelles, gelatin hydrogels incorporating mixed 
SEW2871-micelles and PRP were incubated in 1 ml of 100 mM phosphate-buffered saline solution 
(PBS, pH 7.4) at 37 °C. At each time point, the PBS supernatant was collected and replaced by fresh 
PBS. After 24 hr incubation, PBS was changed to PBS containing 10 μg ml-1 collagenase, and the 
supernatant was collected at different time intervals. The supernatant containing SEW2871 released 
was freeze-dried, and then the sample was re-dissolved in 100 vol% acetonitrile. The amount of 
SEW2871 was measured by the HPLC. The experiment was independently performed for 4 samples 
per experimental group at each sampling point.  
To evaluate the in vivo release of SEW2871, gelatin hydrogels incorporating mixed 
SEW2871-micelles and PRP were implanted into the back subcutis of 6-week-old female ddY mice 
(Shimizu Laboratory Supply, Kyoto, Japan). At each time point, the hydrogel was collected and 
incubated with 1 ml collagenase solution (1 mg/ml) at 37 °C until to the complete digestion. The 
resulting solution was freeze-dried, and then the sample was re-dissolved in 100 vol% acetonitrile, 
followed by the similar determination of SEW2871 amount. The experiment was performed for 4 
samples per experimental group at each sampling point. 
 
2.7. In vitro and in vivo release tests of PRP from gelatin hydrogels incorporating mixed SEW2871-
micelles and PRP 
TGF-β1 and SDF-1 were radioiodinated according to the conventional chloramine-T method 
as previously described [27]. Briefly, 5 μl of Na125I was added into 20 μl of TGF-β1 and SDF-1 
solution (R&D system, IC., Minneapolis) in 0.5 M potassium phosphate-buffered solution (pH 7.5) 
containing 0.5 M NaCl. Then, 0.2 mg/ml chloramine-T in the buffer (100 μl) was added to the 
solution mixture. After vortex mixing at room temperature for 2 min, 100 μl of PBS containing 0.4 
mg sodium metabisulfate was added to the reacting solution to stop the radioiodination. The solution 
mixture was passed through a PD-10 desalting column (GE Healthcare Life Sciences, Chalfont St 
Giles, UK) to remove the uncoupled, free 
125
I molecules from the 
125
I-labeled TGF-β1 and SDF-1 
using PBS as an eluting solution. 
125
I-labeled TGF-β1 (2 μl) and 
125
I-labeled SDF-1 (2 μl) were mixed 
with PRP (18 μl), respectively. The mixed solutions of TGF-β1 (20 μl) and SDF-1 (20 μl) were then 
sorbed into the hydrogels incorporating SEW2871- micelles freeze-dried (2 x 2 x 6 mm
3
), followed by 
leaving at 4 °C overnight to allow the solution to incorporate into the hydrogels.  
For the in vitro release study, the hydrogels incorporating mixed SEW2871-micelles and 
TGF-β1 or SDF-1 was incubated in 1 ml of PBS solution (pH 7.4) at 37 °C. At each time-point, the 
PBS supernatant was collected and replaced by the same volume of fresh PBS. The radioactivity of 
PBS supernatant was measured by a gamma counter (ARC-380 CL, Aloka Co., Ltd, Tokyo, Japan) to 
evaluate the time profiles of TGF-β1 or SDF-1. The experiment was independently performed for 4 
samples per experimental group at each sampling point. For the in vivo release study, the hydrogel 
was implanted into the back subcutis of 6-week-old female ddY mouse. At different time intervals, 
the hydrogels were taken out to measure the radioactivity remaining by the gamma counter. The 
experiment was independently performed for 4 samples per experimental group at each sampling 
point. 
 
2.8. In vivo degradation test of gelatin hydrogels incorporating mixed SEW2871-micelles and PRP 
To evaluate the in vivo degradation profiles of gelatin hydrogels, the implantation of 
125
I-
labeled hydrogels was performed according to the method previously reported [24]. Briefly, 20 μl of 
[
125
I]Boltone-Hunter reagent solution in benzene was evaporated at room temperature. The resultant 
solid reagent was dissolved in 1 ml of PBS and the resulting solution (20 μl) was sorbed into the 
freeze-dried gelatin hydrogel, followed by leaving at 4 °C overnight to introduce 
125
I into the amino 
groups of gelatin. The radioiodinated hydrogels were washed with double distilled water (DDW) 
thoroughly for to exclude the uncoupled. Following the implantation into the back subcutis of mice, 
the hydrogels were taken out at different time intervals to count the radioactivity remaining by the 
gamma counter. The experiment was independently performed for 4 samples per experimental group 
at each sampling point. 
 
2.9. In vitro macrophage migration and in vivo recruitment tests  
Mouse J774.1 macrophage-like cells were cultured in Roswell Park Memorial Institute 
(RPMI) 1640 medium supplemented with 10 vol% fetal bovine serum (FBS), and 100 U/ml penicillin 
and streptomycin at 37 °C in a 5% CO2-95% air atmospheric condition. Detached the J774.1 cells 
(1x10
5
 cells/ well) were suspended in the serum-free medium. Lower chambers in transwells 
(Corning Costar, Lowell, MA) were filled with serum-free medium including various doses of 
SEW2871 with or without PRP. Cells (1x10
5
 cells/ well) were seed into the membrane of upper 
chamber in transwells and incubated 4 hr at 37 °C. After incubation, the membranes were washed 
with PBS, and non-migrated cells on the top of the membranes were removed using a cotton swab. 
The migrated cells were fixed with 4 wt% paraformaldehyde, followed by leaving it for 30 min at 
room temperature. After washing with PBS, cells were stained with 0.1 vol% crystal violet in 200 mM 
2-(n-morpholino)ethanesulfonic acid (MES, pH 6.0) and keep it for 30 min. The membranes were 
washed with PBS 2 times and observed by a microscope (Carl Zeiss, Jena, Germany). The number of 
migrated macrophages was counted from the images taken at 20x magnification randomly selected 
(40 images/experimental group). The experiment was independently performed for 4 samples per 
experimental group. 
For the in vivo macrophages recruitment study, gelatin hydrogels incorporating SEW2871-
micelles with or without PRP were implanted into a critical-size bone defect of rats and taken out 3 
days after implantation. Samples were fixed with 4 wt% paraformaldehyde in PBS at 4 °C for 24 hr, 
equilibrated in PBS containing 15 wt% sucrose at 4 °C for 24 hr, and then in PBS containing 30 wt% 
sucrose at 4 °C for further 24 hr. The samples were embedded in Tisse-tek OCT compound (Sakura 
Finetek Inc., Tokyo, Japan), and frozen in liquid nitrogen. The 6 μm- thickness sections were cut at 
the center of samples and washed with PBS, blocked with 5 wt% BSA solution for 30 min at room 
temperature before incubation with a mouse anti-rat CD68 (1:100, mouse igG1, AbD Serotec (ED1) 
for 1 hr at room temperature. Then, the sections were stained with streptavidin Alexa Flour 488 dye 
(Molecular Probes, Invitrogen Corporation, Ltd., CA) for 1 hr at room temperature and cell nuclei 
were finally stained with Hoechst 33258 (Nacalai Tesque Inc., Kyoto, Japan). After washing, the 
sections were mounted with Vectashield
®
 (Vector Laboratories, Burlingame, CA). The images were 
taken on a fluorescent microscope (Apotome, Lmager.Z1, Carl Zeiss, Jena, Germany). The number of 
macrophages recruited to gelatin hydrogels was counted from the images taken at 40x magnification 
randomly selected (30 images/experimental group). The experiment was independently performed for 
4 samples per experimental group.  
For histological examination, the samples were fixed with 4 wt% paraformaldehyde in PBS 
at room temperature for 24 hr, decalcified with PBS containing 9 wt% ethylenediamine tetraacetic 
acid disodium salt and 10 wt% ethylenediamine tetraacetic acid tetrasodium salt (EDTA) solution at 
room temperature for 7 days. The EDTA solution was changed very other day. After decalcification, 
the samples were embedded in Tissue-Tek OCT Compound (Sakura Finetek Inc., Tokyo, Japan), and 
frozen in liquid nitrogen. The tissue sections (6 μm-thick) were cut at the center of samples, followed 
by staining with hematoxyline and eosin (H&E) and masson trichrome to observe the bone tissue 
newly formed. The images were taken under the microscope (AX80 Provis, Olympus Ltd., Tokyo, 
Japan) at 10x magnification. 
 
2.10. In vivo bone defect experiment 
A bone defect model of rat ulna was prepared to evaluate the bone regeneration after 
implantation of gelatin hydrogels incorporating SEW2871-micelles containing 15 μg SEW2871 
and/or 20 μl of PRP. Male F344 (rat 12 weeks old) were used under standard sterile conditions 
according to the procedure previously reported [28]. Briefly, the rats were anesthetized with an 
intraperitoneal injection of pentobarbital sodium solution (40 mg/kg body weight). After shaving the 
hair and disinfection with 70 vol% ethanol, a longitudinal incision was made along the forearm skin 
of rats. The periosteum was incised circumferentially to approach to the ulna bone. A critical defect of 
6 mm length was then created at the middle position of ulna bone by using a side-cutting diamond 
disk and a high-speed micromotor under an abundant irrigation with the sterile saline solution [29]. 
The hydrogel was implanted into the defect, while the periosteum and overlying muscle were 
repositioned with an absorbable polydioxanone suture (Ethicon 5-0, NJ). Then, the wound was closed 
with a non-absorbable polypropylene suture (Ethicon 5-0, NJ). The experiment was independently 
performed for 4 samples per experimental group at each sampling point. 
 
2.11. Evaluation of gene expression at bone defects with reverse transcription (qRT-PCR) 
The hydrogels incorporating SEW2871-micelles and/or PRP implanted at the defects were 
taken out 3 and 10 days after implantation. Then, the hydrogels were incubated in 1 ml collagenase 
solution (1 mg/ml) at 37 °C until to the complete digestion, and then cells were collected. The total 
RNA was extracted by using Trizol (Invitrogen, Carlsbad, CA) according to the manufacturer’s 
instructions. The RNA pellets were then dissolved in 20 μl of RNase-free water, after which the RNA 
yields were estimated based on the ratio of A260/A280. cDNA was then synthesize using a 
SuperScript VILO cDNA synthesis kit  (Invitrogen Corporation, Ltd., CA) according to the 
manufacturers’ instructions. Real-time polymerase chain reaction (PCR) was performed on a Prism 
7500 real-time PCR thermal cycler (Applied Biosystems, Foster City, CA) from 10 ng of cDNA in a 
total volume of 25 μl containing Power SYBR Green PCR Master Mix (Applied Biosystems) and 10 
mM of each primer (Table 1) to analyze the mRNA expression level of TNF-a, IL-10, TGF-β1, and 
OPG genes. The reaction mixture was incubated for the initial denaturation at 95 °C for 10 min, 
followed by 40 PCR cycles. Each cycle consisted of the following two steps; 95 °C for 15 s and 60 °C 
for 1 min. Each mRNA expression level was normalized by the expression level of glyceraldehyde- 3-
phosphate dehydrogenase (GAPDH) as an internal control. The expression level of every group was 
reported as the value normalized to that of the SHAM group (the bone tissue collected from the rats 
which did not receive the operation and hydrogels implantation). The experiment was independently 
performed for 4 samples per experimental group. 
 
2.12. Evaluation of bone tissue regeneration at the defects 
The bone tissue regenerated at the defect was evaluated 6 weeks later by radiological, micro-
computed tomography (μCT), peripheral quantitative computed tomography (pQCT), and histological 
examinations. The radiological examination was performed under the softX-ray machine (Hitex-100, 
Hitachi Ltd., Tokyo, Japan) at 56 kV and 2.5 mA for 20 sec. Three-dimensional images of bone 
regenerated at the defects were visualized with the CT scans (X-RAY CT System, SMX-100CT-SV3 
TYPE, Shimadzu Ltd., Kyoto, Japan). Samples were scanned over a fixed length of bone with a 20 
mm sample holder at a resolution of 20 mm, energy of 30 kV, current of 25 mA, and exposure time of 
300 msec. The 2-dimensional images were reconstructed and submitted to the VGStudio MAX 1.2 
software (Volume Graphics GmbH, Heidelberg, Germany) for processing to produce the 3-
dimensional images of bone regenerated. The bone mineral density (BMD) of whole cortical 
compartment of bone regenerated was analyzed by using a highly accurate multi-slice pQCT (XCT 
Research SAþ, Stratec Medizintechnik, GmbH, Pforzheim, Germany). The histological examination, 
the samples were fixed with 4 wt% paraformaldehyde in PBS at room temperature for 24 h, 
decalcified and neutralized as described previously. Then, the samples were embedded in Tissue-Tek 
OCT Compound (Sakura Finetek Inc., Tokyo, Japan), and frozen in liquid nitrogen. The tissue 
sections (6 μm-thick) were cut at the center of samples, followed by staining with hematoxyline and 
eosin (H&E) and masson trichrome to observe the bone tissue newly formed. The images were taken 
under a microscope (AX80 Provis, Olympus Ltd., Tokyo, Japan) at 10x magnification. 
 
2.13. Statistical analysis 
All the statistical data were expressed as the mean ± standard error of the mean. The data 
were analyzed by ANOVA to determine the statistical significance between the two mean values. P 
values less than 0.05 were considered to be significant. 
 
  
3. Results  
3.1. In vitro and in vivo release profiles of SEW2871 and PRP growth factors from gelatin 
hydrogels incorporating mixed SEW2871-micelles and PRP and degradation of hydrogels  
Figure 1 shows the in vitro release profiles of SEW2871, TGF-β1, and SDF-1 from gelatin 
hydrogels. Among various PRP growth factors, TGF- β1 and SDF-1 of representative factors related 
to bone regeneration and cells recruitment were chosen to evaluate the PRP release profiles. In PBS, 
20 and 30 % of SEW2871 and PRP growth factors were released from gelatin hydrogels for 12 hr, but 
thereafter no release. After the initial PBS change to collagenase PBS, their release with time was 
observed. The similar time profile was observed for hydrogels degradation. The time profiles of 
SEW2871 and PRP release was in a good accordance to those of hydrogels degradation.  
Figure 2 shows the in vivo profiles from gelatin hydrogels incorporating mixed SEW-
micelles and PRP. Within 7 days, about 97 % of SEW2871 was released while the amount of TGF-β1 
and SDF-1 released was about 90 %. SEW2871 was not detected 14 days later, while the 
radioactivities of TGF-β1 and SDF-1 still remained. The release profiles of SEW2871 and PRP growth 
factors were similar to those of gelatin degradation.  
 
3.2. In vitro macrophages migration assay  
Figure 3 shows the results of in vitro microphages migration by SEW2871 and/or PRP. The 
number of macrophages migrated in the medium containing 15 μg of SEW2871 was higher than that 
of 7.5 μg and 15 μl of PRP. Comparing to the control group (without SEW2871 and PRP), the 
number of migrated macrophages in the medium containing SEW2871 or/and PRP was significantly 
increased. The number of macrophages migrated in mixed SEW2871 and PRP also increased. 
Especially, in 15 μg of SEW2871 and 15 μl of PRP, the number of macrophages migrated was 
significantly higher than that of PRP only. 
 
3.3. In vivo macrophage recruitment into gelatin hydrogels incorporating mixed SEW2871-micelles 
and PRP 
Figure 4 shows the in vivo recruitment of macrophages into gelatin hydrogels 3 days after 
implantation. A high number of macrophages recruited and a large amount of collagen formed were 
around gelatin hydrogels incorporating mixed SEW2871-micelles and PRP implanted. Macrophages 
were observed around gelatin hydrogels incorporating SEW2871 and/or PRP (Figure 4 C). The 
number of macrophages recruited to the gelatin hydrogel incorporating 7.5 μg of SEW2871 or PRP 
did not significantly increase comparing with that gelatin hydrogel incorporating PBS. The number 
of macrophages recruited around gelatin hydrogels incorporating mixed SEW2871-micelles 
containing 15 μg SEW2871, and 15 μl of PRP increased to a significantly great extent compared 
with those incorporating PBS or lower amount (7.5 μg) of SEW2871.  
 
3.4. Gene expression of tissue around gelatin hydrogels incorporating SEW2871-micelles and/or 
PRP 
Figure 5 shows the gene expression levels of inflammatory cytokines and OPG of cells in the 
gelatin hydrogels 3 and 10 days after implantation. The expression levels of TNF-α, IL-10, and TGF-
β1 increased for gelatin hydrogels incorporating SEW2871-micelles and/or PRP 3 days later 
comparing with those of SHAM group. The expression levels of TNF-α and TGF-β1 were 
significantly increased by gelatin hydrogles incorporating mixed SEW2871-micelles and PRP. 
However, siginificant difference in the levels of IL-10 and OPG expression were not observed. On 
the other hand, at 10 days, the expression level of TNF-α was decreased, whereas that of IL-10 was 
increased as compared with the expression levels for gelatin hydrogels alone 3 days after 
implantation. The mRNA expression levels of TGF-β1 and OPG of cells in gelatin hydrogels 
incorporating mixed SEW2871 micelles and PRP significantly increased compared with those of 
other groups.  
 
3.5. Bone regeneration by gelatin hydrogels incorporating mixed SEW2871-micelles and PRP in 
bone defect  
Figure 6 shows the soft X-ray and micro-CT images of bone tissues regenerated. The bone 
formation in the defects implanted with gelatin hydrogels incorporating PBS or SEW2871-micelles 
was scarcely observed. On the contrary, gelatin hydrogels incorporating mixed SEW2871-micelles 
and PRP induced bone regeneration. Comparing with the hydrogel incorporating PRP, bone 
formation was observed in the defect implant with hydrogels incorporating mixed SEW2871-
micelles and PRP. The size of bone regenerated in the defect with hydrogels incorporating mixed 
SEW2871-micelles and PRP was larger than that of gelatin hydrogels incorporating either 
SEW2871-micelles or PRP.  
Figure 7 shows the histological images of bone regenerated in the bone defects of rats after 
implantation of gelatin hydrogel incorporating mixed SEW2871-micelles and PRP. New bone 
tissues were observed at the bone defect implanted with gelatin hydrogels incorporating mixed 
SEW2871-micelles and PRP. Although the collagen tissue formation was not seen at the defect 
implanted with PBS incorporated into gelatin hydrogels, collagen tissues were regenerated from the 
edge of bone defect implanted with gelatin hydrogels incorporating SEW2871-micelles or PRP. The 
bone defect implanted with gelatin hydrogels incorporating mixed SEW2871-micelles and PRP was 
completely coccupied with collagen tissues.  
Figure 8 shows the quantitative results of the area percentage of matured collagen to collagen 
newly formed and bone mineral density. The percentage of matured collagen was significantly 
higher for the gelatin hydrogels incorporating mixed SEW2871-micelles and PRP than that of gelatin 
hydrogels (Figrue 8 A). The defect implanted with gelatin hydrogels incorporating mixed SEW2871-
micelles and PRP was regenerated at significantly higher bone mineral density, comparing with that 
of the hydrogels incorporating SEW2871-micelles or PRP. 
4. Discussion 
The process of bone healing can be classified into four histologically distinguishable stages: 
inflammation, fibrous, callus, and bone formation. Inflammation is the initial and the most vital stage 
from the viewpoint of bone regeneration [4, 30-32]. Macrophages are typical immune cells which 
infiltrate into defected sites and have a key role in the modulation of the inflammatory response [5, 
33, 34]. The hypothesis of this study is that a dual release of SEW2871 and PRP from gelatin 
hydrogels stimulates macrophage recruitment and modulates inflammation, resulting in enhanced 
bone regeneration. SEW2871 has an inherent ability to enhance the recruitment of macrophages [15, 
17]. PRP has a potential to promote tissue regeneration because it contains various growth factors 
[18, 20] . The present study experimentally demonstrates that the enhancement of macrophages 
recruitment promoted the bone regeneration.  
Our previous researches have demonstrated that the gelatin hyrogels could controlled release 
various growth factors of TGF-β1, SDF-1, bFGF, and BMP-2, [24, 35-37] or low molecular weight 
and water-insoluble drugs in a controlled fashion [38-42]. In this study, water-insoluble SEW2871 
was solubilized into water by the incorporation into LAo-grafted gelatin micelles. The micelles of 
SEW2871 water-solubilized were homogenously incorporated into the gelatin hydrogels. PRP was 
also incorporated into the gelatin hydrogels. Most of growth factors in PRP are positively charged at 
the physiological pH. The hydrogels of negatively charged gelatin with an IEP of 5.0 can 
electrostatically interact with the growth factors of positive charge. The doses of SEW2871-micelles 
and PRP were selected according to the appropriate dose demonstrated by other researches [15, 17, 
20]. The time profile of SEW2871 and PRP release from gelatin hydrogels was similar to that of 
degradation of gelatin hydrogels (Figure 1). This indicates that the gelatin hydrogel is a proper 
carrier for the control release of PRP growth factors and SEW2871-micelles. Among various types 
of the growth factors, PRP, TGF-β1 and SDF-1 were representatively selected to evaluate the release, 
because TGF-β1 is the highest concentration in PRP, and SDF-1 is one of important factors for cells 
recruitment. Compared with the data of our previous researches, the release rate of growth factors 
from the gelatin hydrogels was somewhat fast and degradation of gelatin was also rapid (Figure 2). It 
may be explained that macrophages accelerated the degradation of biomaterials [43, 44]. Mixed 
SEW2871-micelles and PRP incorporated in gelatin hydrogels showed the synergistic capacity of 
migration and recruitment of macrophages compared with SEW2871-micelles or PRP alone (Figures 
3 and 4). The SEW2871-micelles and PRP alone also enhanced the macrophages movement. 
However, the mechanism of macrophages recruitment enhancement by PRP is not clear yet at 
present. The macrophages recruitment may be explained by the paracrin factors secreted from 
mesenchymal stem cells. Chen et al. [45] have demonstrated that bone marrow-derived 
mesenchymal stem cells secret high levels of several chemokines such as macrophage inflammatory 
proteins (MIP)-1, 2 and macrophage chemoattractant protein (MCP)-5. MIP and MCP are major 
chemoattractants for macrophages and play a key role in macrophage recruitment. When implanted 
into the back subcutis of mice, MSC incorporated glass cylinders induced high recruitment of 
macrophages compared with the original cylinder [46]. Thus, it is possible that mesenchymal stem 
cells are associated with macrophage recruitment by effective factors released. It is demonstrated 
that mesenchymal stem cells affect the macrophage recruitment. The bone marrow-derived 
mesenchymal stem cells, together with inflammatory cells can be recruited by SDF-1 
chemoattractant [47, 48]. Taken together, several chmokines present in PRP and the paracrin factors 
secreted from mesenchymal stem cells recruited by SDF-1 of PRP would modify the macrophages 
recruitment. In the study, mixed SEW2871-micelles and PRP are released. It is highly conceivable 
that the controlled release enhanced the action of SEW2871 on macrophages and PRP on 
mesenchymal stem cells for factors secretion, resulting in the synergistic enhancement of 
macrophages recruitment.  
The recruitment of macrophages has been studied by many researchers in terms of tissue 
regeneration. The deficiency of macrophages at tissue defects delayed the process of the tissue 
regeneration because macrophages play a important role in the phagocytosis or removal of pathogen 
and initiation of relative gene expression for tissues repairing [11, 49]. In terms of bone regeneration, 
few papers have been published on the macrophage recruitment. Xing et al. [50] have demonstrated 
that macrophages recruited by C-C chemokine receptor (CCR) 2 modulated the function of 
osteoclasts and affected the subsequent bone fracture healing. 
Inflammatory responses are associated with pro-inflammatory and anti-inflammatory 
cytokines. Pro-inflammatory cytokines, such as TNF-α, IL-1β, and IL-6, are known as yhr mediators 
of foreign body reactions and cause further tissue damage and cell death. On the other hand, anti-
inflammatory cytokines, IL-4, IL-10, and TGF-β1 assist tissue repairing. Thus, the production of pro-
inflammatory and anti-inflammatory cytokines is a key to modify inflammation response and to 
predict the regeneration ability. The gene expression level of TNF-α at the tissue around the 
implantation site of gelatin hydrogels incorporating mixed SEW2871-micelles and PRP 3 days after 
implantation was significantly higher than that of SHAM (no inflamed bone) and PBS groups. TNF-
α is mainly expressed by macrophages and other inflammatory cells [32]. It is demonstrated that the 
high number of macrophages recruited may contribute to the high level of TNF-α expression. The 
levels of anti-inflammatory cytokines, such as TGF-β1 and IL-10, were similar between hydrogels 
incorporating mixed SEW2871-micelles and PRP group and only PBS group 3 days after 
implantation. However, the levels of pro-inflammatory cytokine were decreased, whereas that of 
anti-inflammatory cytokines was increased in gelatin hydrogels 10 days after implantation. The 
levels of anti-inflammatory cytokine, TGF-β1 compared with hydrogels incorporating SEW2871-
micelles or PRP. In addition, the expression level of osteoprotegerin, osteoclastogenesis inhibitory 
factor, increased. On the other hand, collagen newly formed was observed around the implantation 
site of hydrogels incorporating mixed SEW2871-micelles and PRP (Figure 4 B). This indicates that 
the modulation of inflammation responses by macrophage recruitment and PRP release can induce 
granulation tissue formation and accelerate the bone formation.  
The production of pro- and anti- inflammatory cytokines are associated with tissue 
regeneration [10, 33]. Pro-inflammatory cytokines secreted that macrophages can play a key role for 
foreign body reactions, such as phagocytosis of dead cells and pathogen killing [51]. On the other 
hand, ant-inflammatory cytokines, such as IL-4, IL-10, and TGF-β1, affect tissue regeneration of 
myfibrobalst activation, collagen formation, and vessel formation [4, 52]. If there is case where the 
pro-inflammation period is shortened and subsequently the anti-inflammation environment can be 
provided, it is possible that regeneration step will be accelerated [7, 53]. Ratanavaraporn et al. [42] 
have demonstrated that the controlled release of mixed anti-inflammatory drug and BMP-2 from 
gelatin hydrogels enhanced bone regeneration to a significantly great extent compared with that of 
BMP-2. On the other hand, inappropriate concentration of pro-inflammation and anti-inflammation 
drugs induce delayed the bone regeneration [7, 54]. Thus, the timely production of anti-
inflammatory cytokines at a suitable concentration is important to enhance bone regeneration.  
Conceptually, macrophages contribute to the process of bone resorption because of their 
osteoclast differentiation, but their roles depend on the biological environments [55-57]. The 
depletion of macrophages in osteoarthritic models reduced osteophytes formations, suggesting that 
macrophages play a critical role in bone deposition [58, 59]. Additionally, macrophages are 
associated with pathologic bone loss and osteoporosis [60, 61]. Taken together, it is well recognized 
that macrophages modify both bone disease and repair.  
The present study showed that hydrogels incorporating SEW2871-micelles alone did not 
enhance bone formation at the bone defect site. On the other hand, hydrogels incorporating mixed 
SEW2871-micelles and PRP showed excellent bone regeneration (Figures 6 and 7). This suggests 
that macrophages recruited and PRP growth factors affected bone regeneration. Dapeng et al. [62] 
and Lacombe et al. [41] demonstrated that TGF-β1 activates macrophages and subsequently produces 
anti-inflammatory cytokines from them. Likewise, various chemokines and TGF-β1 are associated 
with the modulation of inflammation and tissue repair [63]. Another possibility is that the mutual 
communication of mesenchymal stem cells and macrophages recruited by SDF-1 of PRP and 
SEW2871. The soluble factors generated by the interaction of mesenchymal stem cells and 
macrophages resulted in the immunosuppression and enhancement of tissue regeneration [64, 65]. 
Thus, we can say with certainty that PRP not only stimulates the recruitment of macrophages, but 
also triggers their activation and the production of anti-inflammatory cytokines which are associated 
with tissue regeneration. In addition, the dual release of SEW2871 and PRP in a controlled fashion 
from gelatin hydrogels modifies the macrophages recruitment and the modulation of inflammation, 
resulting in enhanced bone regeneration.  
  
5. Conclusions 
 The present study experimentally demonstrated that the dual release of a macrophage 
recruitment agent, SEW2871 and PRP in a controlled fashion from the gelatin hydrogels enhanced the 
bone regeneration at a bone defect. The higher number of macrophages recruited was observed around 
gelatin hydrogels incorporating mixed SEW2871-micelles and PRP compared with those 
incorporating either SEW2871-micelles or PRP. In addition, the hydrogels decreased the production 
of pro-inflammatory cytokine, but increased that of anti-inflammatory cytokines. The controlled 
release of SEW2871 and PRP from the gelatin hydrogels recruited macrophages into the bone defect 
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Figure 1. (A) In vitro release profiles of SEW2871 (open marks) from gelatin hydrogels incorporating 
mixed SEW2871-micelles and PRP and hydrogels degradation (solid marks) in PBS with or without 
collagenase at 37 °C. (B) In vitro release profiles of TGF-β1 (open marks) and SDF-1 (Solid marks) 
from gelatin hydrogels incorporating mixed 125I-labeled TGF- β1 and SDF-1 in PBS with or without 
collagenase at 37 °C. The PBS solution was changed to that with collagenase at the time indicated 
with an arrow.    
 
Figure 2. (A) In vivo release profiles of SEW2871 (open marks) from gelatin hydrogels incorporating 
mixed SEW2871-micelles and PRP and hydrogel degradation (solid marks) after implantation into the 
back subcutis of mice. (B) In vivo release profiles of TGF-β1 (open marks) and SDF-1 (Solid marks) 
from gelatin hydrogels incorporating mixed 125I-labeled TGF- β1 and SDF-1 after implantation into 
the back subcutis of mice. 
 
Figure 3. In vitro macrophages migration by mixed SEW2871 and/or PRP 4 hr after incubation. *p < 
0.05; significant against the value of control group without SEW2871 nor PRP, †p < 0.05; significant 
against the value of PRP group alone.  
 
Figure 4. In vivo macrophages recruitment by gelatin hydrogels incorporating mixed SEW2871-
micelles and/or PRP into critical-size bone defects 3 days after implantation. Then, cells were fixed 
with 4% paraformaldehyde and stained with (A) H&E (B) Masson’s trichrome, and (C) CD68, a 
macrophage surface marker (scale bar = 100 µm, C: collagen). The number of recruited macrophage 
was counted (D).  *p < 0.05; significant against the value of gelatin hydrogels incorporating PBS. †p 
< 0.05; significant against the value of gelatin hydrogels incorporating PRP and 7.5 µg of SEW2871 
group.  
 
Figure 5. Gene expression of TNF-α, IL-10, TGF-β1, and OPG of cells in gelatin hydrogels 
incorporating mixed SEW micelles and/or PRP (A) 3 days and (B) 10 days after implantation into the 
bone defects. *p < 0.05; significant against the value of SHAM group, †p < 0.05; significant against 
the value of PBS group, ‡p < 0.05; significant between the two experimental groups. 
 
Figure 6. (A) Soft X-ray images of bone regenerated at the defects 6 weeks after implantation of 
gelatin hydrogels incorporating SEW micelles and/or PRP. (B) Three-dimensional µCT images of 
bone regeneration at the defects 6 weeks after implantation of the same hydrogels. The bone parts 
regenerated were indicated with arrows. 
 
Figure 7. Histological images of bone regenerated in the ulna critical-sized defects of F344 rats 
implanted with the gelatin hydrogels. The sections were cut at the center of samples and stained with 
(A) hematoxylin and eosin (H&E) and (B) Masson’s trichrome. (C: collagen, M: muscle, Scale bar = 
1 mm).  
 
 
Figure 8. (A) Percentage of matured collagen to collagen newly formed. (B) Bone mineral density 
(BMD) of bone regenerated 6 weeks after implantation, analyzed by pQCT. *p < 0.05; significant 
against the value of gelatin hydrogels incorporating PBS group, †p < 0.05; significant against the 
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